GenScript, Euroimmun enter distribution agreement

Create PDF

July 2022—GenScript USA has reached an agreement with Euroimmun US, a Perkin­Elmer company, for the distribution of the GenScript cPass SARS-CoV-2 Neutralization Antibody Detection Kit in the United States and Canada.

The kit has received FDA emergency use authorization as a serology test for neutralizing antibodies to identify an adaptive immune response in people with recent and prior SARS-CoV-2 infections. The kit is also CE marked and has received Singapore’s Health Sciences Authority provisional approval as well as regulatory approval in Brazil and Argentina.